A body area network as a pre-screening surrogate to the polysomnography

Out of 60 million Americans suffering from sleep disorder, an estimated 18 million have sleep apnea. According to the U.S. Department of Health & Human Services, sleep apnea is a chronic condition that disrupts a patient’s sleep. While the annual cost of treating sleep apnea patients in the United States is approximately $3.18 billion (including screening costs) it is estimated that untreated sleep apnea may cause $3.4 billion in additional medical costs. A polysomnography (PSG) is an all-night sleep study which monitors various physical functions during sleep including electrical activity of the heart, brain wave patterns, eye movement, muscle tone, body movements, and breathing. It is currently, the most accurate and sophisticated test for the diagnosis of sleep-disordered breathing (SDB), but also, the most expensive. The cost of an overnight sleep study is estimated between $900 and $3,000. In addition, the PSG is not mobile and has to be administered outside a patient’s home. The Long QT Syndrome (LQTS) is a
rhythm disorder that causes erratic (unpredictable) heartbeats. The LQTS has been linked to patients with the most severe form of sleep apnea. If LQTS is left untreated, sudden
cardiac death may occur.